Avient Corporation (AVNT) Guidance & Earnings Results

On 2026-10-09 Avient Corporation reaffirmed guidance: "Full year and third quarter 2026 financial guidance previously provided on August 6,…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AVNTAvient CorporationFollow AVNT — free

Specialty Chemicals · Basic Materials

—

Price chart with a free account

Market cap: 3.8B
P/E TTM: 22.2
Dividend yield: 2.7%
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
9 Oct 26	Reaffirmed	Full year and third quarter 2026 financial guidance previously provided on August 6, 2026. · full year
6 Aug 26	Raised	Adjusted EPS raised to $3.10-$3.25 from $2.93-$3.17; adjusted EBITDA raised to $575-$603 million · full year
7 May 26	Reaffirmed	Full-year adjusted EPS $2.93-$3.17, adjusted EBITDA $555-$585M · full year
12 Feb 26	Raised	FY2026 adjusted EPS $2.93-$3.17 (4-12% growth); adjusted EBITDA $555-$585M (2-7% growth) · full year
5 Nov 25	Reaffirmed	FY adjusted EPS guidance $2.77-$2.87; adjusted EBITDA guidance updated to $540-$550M. · full year
1 Aug 25	Raised	FY25 adjusted EPS narrowed to $2.77-2.87 from $2.70-2.94; FY25 adjusted EBITDA $545-560M; Q3 adjusted EPS $0.70. · full year

Avient Corporation — questions

What guidance did Avient Corporation give?: On 2026-10-09: "Full year and third quarter 2026 financial guidance previously provided on August 6, 2026."
When does Avient Corporation report earnings?: Avient Corporation's next earnings report is expected on 2026-11-04.

Every figure on this page comes from Avient Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.